Literature DB >> 1696633

Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells.

J Racevskis1.   

Abstract

Proviral copies of mouse mammary tumor virus (MMTV) are known to be amplified in certain T-cell lymphomas. Transcription of the amplified MMTV proviruses was studied in detail in two T-cell lymphoma lines and showed the production of deletions and premature termination of env mRNAs and the premature termination of gag transcripts. EL-4 cells produce three env mRNAs, and sequence analysis of cDNAs of the two smaller transcripts revealed large deletions encompassing the 3' half of the env gene. The deletion in at least one of the altered transcripts appeared to be produced by a splicing mechanism. T-cell lymphoma line ML of DBA/2 mice also synthesizes two smaller env transcripts, both of which result from premature termination of transcription. Both lines transcribe high levels of gag mRNAs of about 0.8 kilobases in length, terminating at the end of the region encoding MMTV phosphoprotein pp21. Restriction enzyme BamHI analysis of the amplified proviruses of EL-4 and ML cells as well as of additional non-mammary tumor cell types containing amplified MMTV proviruses suggested that the amplified proviruses were derived from exogenous viruses, or activated endogenous provirus MTV-1 in the case of DBA/2 strain tumor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696633      PMCID: PMC247865     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Transcription termination and 3' processing: the end is in site!

Authors:  M L Birnstiel; M Busslinger; K Strub
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

2.  Structural alterations in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice.

Authors:  W T Lee; O Prakash; D Klein; N H Sarkar
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

3.  Sequence organization and molecular cloning of mouse mammary tumor virus DNA endogenous to C57BL/6 mice.

Authors:  D O Peterson; K G Kriz; J E Marich; M G Toohey
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure.

Authors:  R Michalides; E Wagenaar; P Weijers
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

5.  Expression of the protein product of the mouse mammary tumor virus long terminal repeat gene in phorbol ester-treated mouse T-cell-leukemia cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Exogenous mouse mammary tumor virus proviral DNA isolated from a kidney adenocarcinoma cell line contains alterations in the U3 region of the long terminal repeat.

Authors:  R J Wellinger; M Garcia; A Vessaz; H Diggelmann
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

7.  Molecular cloning and sequencing of the MTV-1 LTR: evidence for a LTR sequence alteration.

Authors:  C A Crouse; R J Pauley
Journal:  Virus Res       Date:  1989-02       Impact factor: 3.303

8.  Analysis of gag proteins from mouse mammary tumor virus.

Authors:  A Hizi; L E Henderson; T D Copeland; R C Sowder; H C Krutzsch; S Oroszlan
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats.

Authors:  H J Theunissen; M Paardekooper; L J Maduro; R J Michalides; R Nusse
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

10.  Absence of mouse mammary tumor virus proviral amplification in chemically induced lymphomas of RF/J mice.

Authors:  R Kraft; S T Ishizaka; S A Okenquist; G Childs; F Lilly; J Lenz
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

View more
  6 in total

1.  Ku antigen-DNA conformation determines the activation of DNA-dependent protein kinase and DNA sequence-directed repression of mouse mammary tumor virus transcription.

Authors:  W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues.

Authors:  A Willer; S Saussele; W Gimbel; W Seifarth; P Kister; C Leib-Mösch; R Hehlmann
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma.

Authors:  S Malarkannan; T Serwold; V Nguyen; L A Sherman; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 4.  Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study.

Authors:  Francesca Parisi; Francesca Lessi; Michele Menicagli; Prospero Civita; Romano Liotti; Francesca Millanta; Giulia Freer; Mauro Pistello; Chiara Maria Mazzanti; Alessandro Poli
Journal:  Infect Agent Cancer       Date:  2022-06-23       Impact factor: 3.698

5.  Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.

Authors:  W Held; A N Shakhov; S Izui; G A Waanders; L Scarpellino; H R MacDonald; H Acha-Orbea
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

6.  A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.

Authors:  Ori Braitbard; Maayan Roniger; Allan Bar-Sinai; Dana Rajchman; Tamar Gross; Hillel Abramovitch; Marco La Ferla; Sara Franceschi; Francesca Lessi; Antonio Giuseppe Naccarato; Chiara M Mazzanti; Generoso Bevilacqua; Jacob Hochman
Journal:  Oncotarget       Date:  2016-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.